Protagonist Therapeutics founder Associate Professor Mark Smythe

Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.

31 October 2016
Associate Professor Mark Smythe ... his research led to new biotech company

University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.

22 August 2016

University of Queensland researchers are developing a new asthma treatment that targets the underlying cause of asthma, rather than just the symptoms.

4 May 2015
During the first three years, 13 young scientists will be trained in areas such as health and nutrition, consumer and sensory science, commercialisation and business leadership. Above: UQ PhD student Ms Titlayo Falade

An industry-backed centre dedicated to creating healthier food choices for Australian and Asian consumers opened at UQ this week. Funded by the Australian Research Council, the ‘Industrial Transformation Training Centre’ has been tasked with...

17 October 2014
Full-flavour caffeine-free coffee is on the way

It will soon be possible to grow premium-quality caffeine-free coffee, tea and cocoa, thanks to research involving University of Queensland expertise.

4 September 2014
The University of Queensland has been awarded more than $26 million for health and medical research, to investigate cancer treatments, pain relief, dengue fever vaccinations and more.

The University of Queensland has been awarded more than $26 million for health and medical research, to investigate cancer treatments, pain relief, dengue fever vaccinations and more.

18 February 2014

The University of Queensland-based Protagonist Therapeutics, Inc. has announced the completion of a $14 million Series B venture financing initiative.

10 July 2013

A successful Brisbane biotechnology company formed by The University of Queensland’s Institute for Molecular Bioscience (IMB) is expanding its collaboration with a publicly traded pharmaceutical company based on the east coast of the United States.

10 December 2012
Professor Robert Parton, from the Institute for Molecular Bioscience, is leading a $7.1 million research project to study the mechanisms behind healthy cells transforming into cancerous cells.

Cutting-edge research that aims to stop the transformation of healthy cells into cancerous cells is one of nine prestigious grants and scholarships awarded to health and medical researchers at The University of Queensland (UQ).

15 December 2011

Wine lovers already appreciate the differences that occur between brands, grape varieties variety and regions and now a world-first project is taking this concept and trying to unlock the signature flavours for some of Australia’s most iconic...

3 August 2011

A Queensland biotechnology company has raised US$9 million (about AUS$11.9 million) to fund the development of new types of therapeutic drugs.

22 September 2006

A University of Queensland academic has criticised economic rationalism as a "dumb" economic theory and has questioned its rise in Australian political thinking.

5 May 1999

The University of Queensland's Centre for Drug Design and Development has launched three spin-off biotechnology companies to further develop intellectual property and commercialise the results of its research.

26 February 1999